Baronova secures $7.5 million in Series B funding - MarketLine Financial Deals

Baronova secures $7.5 million in Series B funding

3 pages — Published Oct 23, 2008
Price $45.00  |  Buy this Report Now

About This Report


Baronova, Inc., a US-based developer of nonsurgical and nonpharmacologic therapies to treat obesity, has secured $7.5 million in Series B funding round led by Allergan, Inc. Existing investors Arboretum Ventures, Highland Capital Partners and Onset Ventures are also participated in the funding round.

Document ID
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author

Cite this Report

MarketLine Financial Deals. "Baronova secures $7.5 million in Series B funding" Oct 23, 2008. Alacra Store. Apr 16, 2014. <>
MarketLine Financial Deals. (2008). Baronova secures $7.5 million in Series B funding Oct 23, 2008. New York, NY: Alacra Store. Retrieved Apr 16, 2014 from <>
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.